Journey Medical (DERM) Non-Current Debt (2020 - 2026)
Journey Medical's (DERM) quarterly Non-Current Debt came in at $22.9 million in Q1 2026, down 1.0% YoY from $23.1 million in Q1 2025, and down 9.51% on a QoQ basis from $25.3 million in Q4 2025.
Journey Medical (DERM) Non-Current Debt (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Non-Current Debt data on file, last reported at $22.9 million in Q1 2026.
- Quarterly Non-Current Debt fell 1.0% year-over-year to $22.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.9 million (down 1.0% YoY) and the FY2025 annual result came in at $25.3 million, up 1.6% from the prior year.
- Non-Current Debt eased to $22.9 million in Q1 2026, from $25.3 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $25.3 million in Q4 2025 to a low of $9.9 million in Q2 2023.
- A 5-year average of $19.2 million and a median of $19.8 million in 2022 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2022 — Non-Current Debt jumped 2341.63% — and 2024, when it tumbled 35.72%.
- Tracing DERM's Non-Current Debt over 5 years: stood at $19.8 million in 2022, then fell by 26.25% to $14.6 million in 2023, then soared by 70.15% to $24.9 million in 2024, then rose by 1.6% to $25.3 million in 2025, then declined by 9.51% to $22.9 million in 2026.
- The last three Non-Current Debt figures came in at $22.9 million (Q1 2026), $25.3 million (Q4 2025), and $19.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 130.00 Mn |
| 10 | Journey Medical | 205.52 Mn | 179.87 Mn | 12.37 Mn | 20.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.47 Mn |
| Mar 31, 2026 | 22.87 Mn |
| Dec 31, 2025 | 25.28 Mn |
| Sep 30, 2025 | 19.53 Mn |
| Jun 30, 2025 | 21.36 Mn |
| Mar 31, 2025 | 23.11 Mn |
| Dec 31, 2024 | 24.88 Mn |
| Sep 30, 2024 | 19.79 Mn |
| Jun 30, 2024 | 19.75 Mn |
| Mar 31, 2024 | 14.68 Mn |
| Dec 31, 2023 | 14.62 Mn |
| Jun 30, 2023 | 9.94 Mn |
| Mar 31, 2023 | 22.84 Mn |
| Dec 31, 2022 | 19.83 Mn |
| Sep 30, 2022 | 19.81 Mn |
| Jun 30, 2022 | 14.79 Mn |
| Mar 31, 2022 | 14.78 Mn |
| Dec 31, 2021 | 812,000.00 |
| Sep 30, 2021 | 14.97 Mn |
| Dec 31, 2020 | 5.22 Mn |